Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma;Metastatizzazione linfonodale e fattori prognostici nel carcinoma differenziato della tiroide

Acta Otorhinolaryngologica Italica

Volumn 29, Issue 6, 2009, Pages 312-316

  Spriano, G ^a   Ruscito, P ^a   Pellini, R ^a   Appetecchia, M ^b   Roselli, R ^a  

^a Department of Otolaryngology

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Extra capsular spread; Nodal metastases; Thyroid carcinoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; THYROID TUMOR; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; YOUNG ADULT;

EID: 77952535636     PISSN: 0392100X     EISSN: 1827675X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 1987;67:251-61.
2. Shaha AR. Management of the neck in thyroid cancer. Otolaryngol Clin North Am 1998;31:823-31.
3. Chonkich GD, Petty GH. Treatment of thyroid carcinoma. Laryngoscope 1992;102:486-91.
4. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A. Survival discriminates for differentiated thyroid cancer. Am J Surg 1990;160:344-7.
5. Dimov RS, Deenichin GP, Damianliev RA, Ouchikov AP, Bacelov MH, Protohristov HAT, et al. Safety and efficacy of modified radical lymph nodes dissection in patients with papillary thyroid cancer and clinically evident lymph nodes metastasis. Folia Med (Plovdiv) 2006;48:17-22.
6. Shindo M, Wu JC, Park EE, Tanzella F. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 2006;132:650-4
7. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 6th edn (UICC). New York: Wiley & Sons, Inc. Publication; 2002.
8. Robbins T, Medina JE, Wolfe GT, Levine PO, Session R. Standardizing neck dissection terminology. Arch Otolaryngol Head Neck Surg 1991;117:601-5.
9. Shaha A. Treatment of thyroid cancer based on risk groups. J Surg Oncol 2006;94:683-91.
10. Cappelli C, Pirola I, Braga M, De Martino E, Morassi ML, Gandossi E, et al. Prognostic factors in well differentiated thyroid carcinoma in patients treated and followed in the same institution. Ann Ital Chir 2006;77:107-13.
11. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of impact of therapy in 576 patients. Am J Med 1981;70:511-8.
12. Fransilla KO. Prognosis in thyroid carcinoma. Cancer 1975;36:1138-46.
13. Mirallie E, Visset J, Sagan C, Hamy A, Le Bodic M, Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 1999;23:970-4.
14. Kim JM, Kim TY, Kim WB, Gong G, Kim SC, Hong SJ, et al. Lymphovascular invasion is associated with lateral cervical lymph node metastasis in papillary thyroid carcinoma. Laryngoscope 2006;116:2081-5.
15. Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996;18:127-32.
16. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 1978;136:107-12.
17. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1986;57:1405-14.
18. McConahey WM, Hay ID, Woolner LB, Van Heerdenn JA, Tylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestation, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978-96.
19. Cady B, Rossi R, Silverman M, Wool M. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 1985;98:1171-8.
20. Cady B, Sedgwick CE, Meissner WA, Bookwalter JR, Romagosa V, Werber J. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976;184:541-53.
21. Cady B, Sedgwick CE, Meissner WA, Woll MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;43:810-20.
22. Tenvall J, Biorklund A, Moller T, Ranstam J, Akerman M. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Cancer 1996;57:1405-14.
23. Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998;85:252-4.
24. Ducci M, Appetecchia M, Marzetti M. Neck dissection for surgical treatment of lymph node metastasis in papillary thyroid carcinoma. J Exp Clin Cancer Res 1997;16:333-5.
25. Caroggio A, Pedroni C. La chirurgia di N nelle neoplasie della tiroide. In: Gli svuotamenti linfonodali del collo nei carscinomi cervico-cefalici. Atti del XXIII Convegno Nazionale di Aggiornamento A.O.O.I., Cervia-Milano Marittima 24/25 settembre 1999.
26. Noguchi S. The influence of regional metastases on prognosis in papillary cancer of the thyroid gland. Vestn Khir Im I I Grek 2005;164:48-51.
27. Reddy RM, Grigsby PW, Molev JF, Hall BL. Lymph node metastases in differentiated thyroid cancer under 2 cm. Surgery 2006;140:1050-4 (discussion 1054-5)
28. Cox DR, Oakes D. Analysis of survival data. London: Chapman Hall; 1984.